Annual Meeting News

DALLAS--(BUSINESS WIRE)--Matador Resources Company (NYSE: MTDR) (“Matador” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Thursday, June 12, 2025, at 9:30 a.m. Central Time. The Annual Meeting will be held in the Fort Worth Ballroom at The Westin Galleria Dallas hotel, located at 13340 Dallas Parkway, Dallas, Texas 75240. A continental breakfast will be provided beginning at 8:30 a.m. Central Time to provide shareholders with the opportunity to meet and interact with dir...

WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (Nasdaq: ALOT) Sends Letter to Shareholders Highlighting Growth Strategy and Strength of Board...

CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2025 annual stockholders’ meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2025. Stockholders also approved Chemed’s executive compensation and the Company’s 2025 Stock Incentive Plan. Dividend Declared Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cas...

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI announces combination of common stock....

HOUSTON--(BUSINESS WIRE)--Phillips 66 today sent a letter to shareholders highlighting the key issues on the ballot at its Annual Meeting on May 21....

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced today that four abstracts with Innate’s drugs in clinical development have been accepted for the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, taking place May 30-June 3, 2025 in Chicago, Illinois. “We are looking forward to participating in the ASCO Annual Meeting 2025, where four abstracts with Innate’s drugs in clinical developmen...

NEW YORK--(BUSINESS WIRE)--DWS Municipal Income Trust (NYSE: KTF) (the “Fund”) announced that the Annual Meeting of Shareholders for the Fund will be held on September 19, 2025 at the offices of DWS Investment Management Americas, Inc., 100 Summer Street, Boston, Massachusetts. Holders of record of common shares and preferred shares of the Fund at the close of business on August 1, 2025 will be entitled to vote at the Annual Meeting and any adjournments or postponements thereof. Important Infor...

DALLAS--(BUSINESS WIRE)--Flowserve Corp. (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, has released the voting results of its 2025 Annual Meeting of Shareholders and announced its quarterly cash dividend. Annual Meeting Results At the virtual Annual Meeting, Flowserve’s shareholders re-elected Sujeet Chand, Ruby R. Chandy, Gayla J. Delly, John L. Garrison, Cheryl H. Johnson, Michael C. McMurray, Thomas B. Okray, R. Scott Rowe, and K...

FALLS CHURCH, Va.--(BUSINESS WIRE)--Women in Technology (WIT) the premier organization contributing to the success of professional women in the Washington, D.C. area technology community, has announced the winners of the 26th Annual Leadership Awards. The awards were presented at WIT’s annual gala held on Thursday, May 15, 2025, at the Hyatt Regency in Reston, VA. The annual WIT Leadership Awards celebrate women who have excelled in entrepreneurship, STEM, government, and corporate sectors. Thi...

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting describing a monitoring and treatment algorithm intended to reverse the rare, severe hyperinflammatory syndrome hemophagocytic lymphohistiocytosis (HLH) that has been associated with systemic e...